NCT01294085
- Conditions
- Biliary Tract Cancer, Biliary Tract Diseases, Biliary Tract Neoplasms, +4 more
- Locations
-
- Osaka Medical Center for Cancer and Cardiovascular Diseases Osaka, Japan
Clinical trial condition
Biliary Tract Cancer
Explore clinical trials studying Biliary Tract Cancer. Study availability and eligibility vary by location and protocol.
163 public trials
57 recruiting studies
Biliary Tract Cancer trial results
NCT00832689
- Conditions
- Biliary Tract Cancer, Biliary Tract Diseases, Biliary Tract Neoplasms, +4 more
- Locations
-
- Severance hospital Seoul, South Korea
NCT00423254
- Conditions
- Adenocarcinoma, Adenoma, Anal Carcinoma, +97 more
- Locations
-
- Arizona Cancer Center Tuscon, Arizona, United States
- Lombardi Comprehensive Cancer Center at Georgetown Washington D.C., District of Columbia, United States
- H Lee Moffitt Cancer Center University of So Florida Tampa, Florida, United States
- Nevada Cancer Institute Sparks, Nevada, United States
NCT00380588
- Conditions
- Biliary Tract Cancer, Biliary Tract Diseases, Biliary Tract Neoplasms, +4 more
- Locations
-
- For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Aichi, Japan
- For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Chiba, Japan
- For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Fukuoka, Japan
- For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Hokkaido, Japan
NCT00123825
- Conditions
- Adenocarcinoma, Biliary Tract Cancer, Biliary Tract Diseases, +12 more
- Locations
-
- Massachusetts General Hospital Boston, Massachusetts, United States
- Beth Israel Deaconess Medical Center Boston, Massachusetts, United States
- Dana-Farber Cancer Institute Boston, Massachusetts, United States
Active, Not Recruiting
A Study of Ramucirumab (LY3009806) or Merestinib (LY2801653) in Advanced or Metastatic Biliary Tract Cancer
NCT02711553
- Conditions
- Advanced Cancer, Biliary Tract Cancer, Biliary Tract Diseases, +10 more
- Locations
-
- The University of Arizona Cancer Center Tucson, Arizona, United States
- UCSF Medical Center at Mission Bay San Francisco, California, United States
- Georgetown University Medical Center Washington D.C., District of Columbia, United States
- University of Florida School of Medicine Gainesville, Florida, United States
Active, Not Recruiting
Rilvegostomig + Chemotherapy as Adjuvant Therapy for Biliary Tract Cancer After Resection (ARTEMIDE-Biliary01)
NCT06109779
- Conditions
- Adenocarcinoma, Bile Duct Diseases, Bile Duct Neoplasms, +14 more
- Locations
-
- Research Site Birmingham, Alabama, United States
- Research Site Phoenix, Arizona, United States
- Research Site Los Angeles, California, United States
- Research Site Orange, California, United States
Active, Not Recruiting
Study of Novel Immunomodulators as Monotherapy and in Combination With Anticancer Agents in Participants With Advanced Hepatobiliary Cancer
NCT05775159
- Conditions
- Adenocarcinoma, Biliary Tract Cancer, Biliary Tract Diseases, +12 more
- Locations
-
- Research Site Birmingham, Alabama, United States
- Research Site Los Angeles, California, United States
- Research Site Orange, California, United States
- Research Site Kansas City, Kansas, United States
Active, Not Recruiting
Adoptive Transfer of Tumor Infiltrating Lymphocytes for Biliary Tract Cancers
NCT03801083
- Conditions
- Adenocarcinoma, Biliary Tract Cancer, Biliary Tract Diseases, +9 more
- Locations
-
- UPMC Hillman Cancer Center Pittsburgh, Pennsylvania, United States
Active, Not Recruiting
SHR-8068 in Combination With Adebrelimab, Bevacizumab, and Platinum-Based Chemotherapy as First-line Treatment in Patients With Advanced Biliary Tract Cancer
NCT06465563
- Conditions
- Biliary Tract Cancer, Biliary Tract Diseases, Biliary Tract Neoplasms, +4 more
- Locations
-
- Jiangsu Province Hospital (The First Affiliated Hospital with Nanjing Medical University) Nanjing, Jiangsu, China
- The First Affiliated Hospital，Zhejiang University School of Medicine Hangzhou, Zhejiang, China